Inhibition of angiogenesis on glycated collagen lattices.
Advanced glycation endproduct (AGE) accumulation in extracellular matrix proteins has been demonstrated in diabetic patients with a significant correlation with the severity of diabetic complications. AGE accumulation induces matrix protein cross-link formation, resulting in an increased stiffness of matrix fibres and the reduction of the susceptibility of matrix proteins to proteolytic degradation. We examined whether glycation-induced collagen cross-linking may affect vascular endothelial cell behaviours such as invasion, proliferation and differentiation, using the in vitro angiogenesis model of capillary-like structure formation in three-dimensional matrices of collagen type I. Endothelial cells cultured on collagen gel with angiogenic factors (the combination of fibroblast growth factor-2 and vascular endothelial growth factor) invaded the underlying collagen matrix, and organized capillary-like cord structures in the gel. We found that endothelial cell invasion into glycated collagen gel was significantly attenuated without any effect on proteinase activity including cell-associated plasminogen activator and matrix metalloproteinase in the conditioned medium. In addition, subsequent capillary-like cord formation was also inhibited in glycated collagen gel. In contrast, endothelial cell proliferation was enhanced on glycated collagen gel with or without angiogenic factors compared with control collagen gel. These results suggest that the structural alterations of extracellular matrix proteins through the glycation-induced cross-link formation affect the interaction between endothelial cell and extracellular matrix, resulting in the impairment of an adequate neovascularization in diabetic patients.
Kuzuya
M
M
Department of Geriatrics, Nagoya University School of Medicine, Japan.
Satake
S
S
Ai
S
S
Asai
T
T
Kanda
S
S
Ramos
M A
MA
Miura
H
H
Ueda
M
M
Iguchi
A
A
D043925:Angiogenesis Inducing Agents / Q000494:pharmacology; D000818:Animals; D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D002465:Cell Movement / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D003094:Collagen / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D010450:Endopeptidases / Q000187:drug effects / Q000378:metabolism; D004730:Endothelium, Vascular / Q000737:chemistry / Q000166:cytology / Q000201:enzymology; D005782:Gels; D017127:Glycation End Products, Advanced / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D006031:Glycosylation; D006801:Humans; D007223:Infant; D018919:Neovascularization, Physiologic / Q000187:drug effects / Q000502:physiology*
D043925:Angiogenesis Inducing Agents; D005782:Gels; D017127:Glycation End Products, Advanced; D003094:Collagen; D010450:Endopeptidases